Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care), slated to be listed on the main market (TASI), posted a net profit of SAR 279.6 million for 2023, down 14% from SAR 326.3 million a year earlier.
| Item | 2022 | 2023 | Change |
|---|---|---|---|
| Revenues | 2,012.39 | 2,326.69 | 15.6 % |
| Gross Income | 612.25 | 616.68 | 0.7 % |
| Operating Income | 369.69 | 312.84 | (15.4 %) |
| Net Income | 326.32 | 279.59 | (14.3 %) |
| Average Shares | 200.00 | 200.00 | - |
| EPS (Riyals) | 1.63 | 1.40 | (14.3 %) |
The profit decline was attributed to a 32% year-on-year (YoY) rise in operating expenses to SAR 292.5 million. Financing costs also increased to SAR 122.2 million, while gross profit margin declined to 27% compared with 30% a year earlier. The operating profit margin fell to 13% in 2023, versus 18% a year ago.
However, revenues surged to SAR 2.32 billion in 2023 as other income also grew to SAR 25.8 million by year-end. Further, Financing revenues went up to SAR 38.2 million during the same year.
In Q4 2023, net earnings dropped 30% to SAR 74 million, compared with SAR 104.91 million in the same period of 2022.
On a quarter-on-quarter basis, net earnings decreased 7.1% from SAR 79.65 million in Q3 2023.
| Item | Q4 2022 | Q4 2023 | Change |
|---|---|---|---|
| Revenues | 540.37 | 662.32 | 22.6 % |
| Gross Income | 176.32 | 182.10 | 3.3 % |
| Operating Income | 97.59 | 79.73 | (18.3 %) |
| Net Income | 104.91 | 73.99 | (29.5 %) |
| Average Shares | 200.00 | 200.00 | - |
| EPS (Riyals) | 0.52 | 0.37 | (29.5 %) |
Total shareholders' equity, after minority interest, reached SAR 1.02 billion at the end of December 2023, compared with SAR 1.89 billion a year before.
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| Q1 2023 | 529.41 | - | 144.40 | - | 72.04 | - | 0.36 |
| Q2 2023 | 545.67 | - | 114.18 | - | 53.92 | - | 0.27 |
| Q3 2023 | 589.29 | 27.6 % | 176.00 | 33.0 % | 79.65 | 14.6 % | 0.40 |
| Q4 2023 | 662.32 | 22.6 % | 182.10 | 3.3 % | 73.99 | (29.5 %) | 0.37 |
| 2023 | 2,326.69 | 15.6 % | 616.68 | 0.7 % | 279.59 | (14.3 %) | 1.40 |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2023 | - | - | - |
| Q2 2023 | 27.31 % | - | 14.46 % |
| Q3 2023 | 27.71 % | - | 14.08 % |
| Q4 2023 | 26.50 % | - | 12.02 % |
| 2023 | 26.50 % | 19.87 % | 12.02 % |
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2023 | 200.00 | - | - | 9.85 |
| Q2 2023 | 200.00 | 1.50 | 1.50 | - |
| Q3 2023 | 200.00 | 1.55 | 1.55 | 4.77 |
| Q4 2023 | 200.00 | 1.40 | 1.40 | 5.10 |
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q3 2023 | - | - | - |
| Q4 2023 | - | - | - |
Q4 2023
| Period | Medical Services | Education | Trade, retail and others |
|---|---|---|---|
| Q1 2023 | 487.77 | 22.33 | 19.31 |
| Q4 2023 | 623.18 | 22.83 | 16.32 |
| Current | |
| Market Cap (M Riyal) | 13,595.20 |
| Enterprise Value (EV) (M) | 15,331.42 |
| Shares Outstanding ((M)) | 232.00 |
| EPS ( Riyal) (TTM) | 1.40 |
| Book Value (BV) ( Riyal) | 5.46 |
| Par Value ( Riyal) | 1.00 |
| Adjusted P/E (Last12) | 48.51 |
| P/E (TTM) | 48.51 |
| Price/book | 12.44 |
| Return on Average Assets (%) (TTM) | 5.9 |
| Return on Average Equity (%) (TTM) | 18.3 |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}